Skip to Content

Sulfur hexafluoride Pregnancy and Breastfeeding Warnings

Sulfur hexafluoride is also known as: Lumason

Sulfur hexafluoride Pregnancy Warnings

This drug should be used only if clearly needed.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of fetal harm at doses up to 17 times the human dose based on body surface area. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Sulfur hexafluoride Breastfeeding Warnings

Use of this drug is not a reason to discontinue breastfeeding since drug absorption by the infant is unlikely. Pumping and discarding breast milk one time after receiving this drug is suggested based on the drug's rapid clearance.

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Lumason (sulfur hexafluoride)." Bracco Diagnostics Inc, Princeton, NJ.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  2. "Product Information. Lumason (sulfur hexafluoride)." Bracco Diagnostics Inc, Princeton, NJ.
  3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide